Login
Toggle navigation
Videos
Categories
Trending
Flash is missing. Download it from
Adobe
.
Alexandre Fraichard, CEO, Genoway
00:00:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Interview of Alexandre Fraichard, CEO of Genoway
Recent Videos
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
Suggestions
00:10:00
John Graziano on Succession Planning for Family Businesses | John Graziano - President, Wealth Management Partner of FFP Wealth Management
00:10:00
Middle Island Resources: Advancing Sandstone Gold Project with New Deposits and Mill Restart Plans
00:00:00
Alligator Bioscience at the ØU Lifescience Investor Conference, November 22, 2023 - Søren Bregenholt , CEO, Alligator Bioscience
00:00:00
Admedus (ASX:AHZ) CEO Wayne Paterson interview
00:10:00
Building a High-Performance Culture: Key Ingredients and Leadership Strategies
00:10:00
Building a Legacy: Reflections on 30 Years in Money Management | Mark Okada, CIO, Highland Capital Management .
00:10:00
Novak Djokovic Launches PTPA to Empower Tennis Players Worldwide and Shapes Future of the Sport|Novak Djokovic,Serbian professional tennis player
00:10:00
Sydney Resources Round-up 2022 Q&A video | Tony Rovira, MANAGING DIRECTOR, Azure Minerals Limited (IE)
00:10:00
Francis Wedin Highlights Vulcan's Sustainable Lithium Brine Project | Francis Wedin , CEO, Vulcan Energy Resources Ltd.
00:10:00
Let's Talk About Your Organization's Retirement Plan | Rene Bruner - Advisor of smith bruer advisors
00:10:00
Empowering Homeless Communities Through Innovative Housing Solutions
00:10:00
Client-Centric Service and Ongoing Monitoring at Lyndon Thomas